Immune signatures predictive of optimal cytoreduction in ovarian cancer

被引：0
|
作者：
Simons, E. [1 ]
Kiet, T. [1 ]
Amanam, I. [1 ]
Ho, M. [1 ]
Fuh, J. [1 ]
Fuh, K. [1 ]
Kapp, D. [2 ]
Odunsi, K. [3 ]
Chan, J. [1 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
107
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Secondary cytoreduction for relapsed ovarian cancer
    Garg, Pankaj Kumar
    Kumar, Rahul
    Choudhary, Deepti
    LANCET ONCOLOGY, 2021, 22 (06): : E230 - E230
  • [32] A Proteomics Panel for Predicting Optimal Primary Cytoreduction in Stage III/IV Ovarian Cancer
    Risum, Signe
    Hogdall, Estrid
    Engelholm, Svend A.
    Fung, Eric
    Lomas, Lee
    Yip, Christine
    Petri, Anette L.
    Nedergaard, Lotte
    Lundvall, Lene
    Hogdall, Claus
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1535 - 1538
  • [33] Concept of optimal surgical cytoreduction in advanced ovarian cancer: A brief critique and a call for action
    Markman, Maurie
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4168 - 4170
  • [34] Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis
    Keskin, Serkan
    Kucucuk, Seden
    Ak, Naziye
    Atalar, Banu
    Sari, Murat
    Sozen, Hamdullah
    Ibis, Kamuran
    Topuz, Samet
    Saip, Pinar
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 101 - 105
  • [35] Evaluation of prognostic factors for advanced ovarian cancer treatment with an emphasis on optimal primary cytoreduction
    Vrhkar, Natasa
    Vakselj, Ales
    Verdenik, Ivan
    Smrkolj, Spela
    Barbic, Matija
    Cvjeticanin, Branko
    Meglic, Leon
    Kobal, Borut
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (7-8): : 509 - 516
  • [36] Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
    Shen, Xiaoyan
    Gu, Xiao
    Ma, Ruiqiong
    Li, Xiaoping
    Wang, Jianliu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [37] Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
    Beissel, Joy M.
    Kendrick, Michael L.
    Podratz, Karl C.
    Bakkum-Gamez, Jamie N.
    GYNECOLOGIC ONCOLOGY REPORTS, 2014, 10 : 25 - 27
  • [38] Predictive immune signatures for cancer immunotherapy - From bench to bedside
    de St Groth, Barbara Fazekas
    McGuire, Helen
    Kao, Steven
    McNeil, Catriona
    Hersey, Peter
    Boyer, Michael
    Vafaee, Fatemeh
    Choi, Clara
    Kwong, Chun-Ting Justin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 69 - 70
  • [39] Defining the Ca 125 value to predict optimal cytoreduction in patients with epithelial ovarian cancer
    Bueno, Gonzalo Arturo Medina
    Barra, Rocko Karina Quinonez
    Ramos, Deyne Maribel Ticona
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2023, 69 (04):
  • [40] Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
    Dhiman, Pravesh
    Bapsy, P. P.
    Patil, C. N.
    Raghupathi, Renu
    SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (03) : 207 - 212
12345